Intellia Therapeutics NTLA
NASDAQ NTLA
$12.27 +0.15 (+1.20%)
As of: Oct 2, 2026 · 3:38 PM EDT

Intellia Therapeutics (NTLA) Return on Assets [ROA] (2016 - 2026)

Updated

Intellia Therapeutics (NTLA) posted Return on Assets [ROA] of -49.42% for Q2 2026, up 0.79 percentage points from -50.21% a year earlier but down 0.08 percentage points from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For FY2025, Intellia Therapeutics' Return on Assets [ROA] came in at -40.51%, down 1.47 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for five consecutive years, with a five-year change of -13.94 percentage points (FY2020 to FY2025).
  • In prior years, Intellia Therapeutics' Return on Assets [ROA] was -39.04% in FY2024 (-6.04 pp), -33.00% in FY2023 (-1.05 pp), -31.95% in FY2022 (-4.90 pp) and -27.05% in FY2021 (-0.49 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -50.21% in Q2 2025 to a high of -20.28% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in 1 of the last eight quarters, with an average year-over-year change of -6.00 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2023, with a gain of 4.21 percentage points; the weakest was Q3 2022, with a drop of 15.91 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -49.34% (Q1 2026), -46.60% (Q4 2025) and -48.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Intellia Therapeutics 1.69 Bn 1.69 Bn - -49.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.42%
Mar 31, 2026 -49.34%
Dec 31, 2025 -46.60%
Sep 30, 2025 -48.83%
Jun 30, 2025 -50.21%
Mar 31, 2025 -45.68%
Dec 31, 2024 -41.15%
Sep 30, 2024 -41.28%
Jun 30, 2024 -38.66%
Mar 31, 2024 -36.46%
Dec 31, 2023 -36.59%
Sep 30, 2023 -34.50%
Jun 30, 2023 -31.23%
Mar 31, 2023 -27.63%
Dec 31, 2022 -34.53%
Sep 30, 2022 -38.71%
Jun 30, 2022 -33.97%
Mar 31, 2022 -29.16%
Dec 31, 2021 -20.28%
Sep 30, 2021 -22.80%
API Access

Intellia Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=NTLA&period=max&api_key=YOUR_API_KEY